(Q46656781)

24 December 2017

title

Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice (English)

1 reference

24 December 2017

1 reference

1 reference

Yukiyasu Kuzumoto

1

1 reference

24 December 2017

Masayuki Sho

2

1 reference

24 December 2017

Naoya Ikeda

3

1 reference

24 December 2017

Kaoru Hamada

4

1 reference

24 December 2017

Takashi Mizuno

5

1 reference

24 December 2017

Satoru Akashi

6

1 reference

24 December 2017

Yoshikazu Tsurui

7

1 reference

24 December 2017

Hisanori Kashizuka

8

1 reference

24 December 2017

Takeo Nomi

9

1 reference

24 December 2017

Atsushi Kubo

10

1 reference

24 December 2017

Hiromichi Kanehiro

11

1 reference

24 December 2017

Yoshiyuki Nakajima

12

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

24 December 2017

published in

Hepatology

1 reference

24 December 2017

volume

42

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

608-617

1 reference

24 December 2017

Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning

cites work

1 reference

Mechanisms of enhanced macrophage-mediated prostaglandin E2 production and its suppressive role in Th1 activation in Th2-dominant BALB/c mice

21 January 2018

1 reference

IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes

21 January 2018

1 reference

C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse.

21 January 2018

1 reference

Reperfusion injury after liver preservation for transplantation

21 January 2018

1 reference

7 January 2021

Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat.

1 reference

7 January 2021

Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury

1 reference

7 January 2021

Effects of immunomodulation with interferon-gamma on hepatic ischemia-reperfusion injury

1 reference

7 January 2021

Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells

1 reference

7 January 2021

Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury

1 reference

7 January 2021

Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver

1 reference

7 January 2021

P-Selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver

1 reference

7 January 2021

Adhesion molecules in liver ischemia and reperfusion

1 reference

7 January 2021

Prostanoid receptors: subtypes and signaling

1 reference

7 January 2021

Prostanoid receptors: structures, properties, and functions

1 reference

7 January 2021

The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis

1 reference

7 January 2021

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

1 reference

7 January 2021

Prostaglandin E2-EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells.

1 reference

7 January 2021

Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth

1 reference

7 January 2021

Differential effect of cyclooxygenase metabolites on proinflammatory cytokine release by Kupffer cells after liver ischemia and reperfusion

1 reference

7 January 2021

Protection of sinusoidal endothelial cells against storage/reperfusion injury by prostaglandin E2 derived from Kupffer cells.

1 reference

7 January 2021

Protection of thermochemotherapeutic-induced lethal acute hepatic necrosis in the rat by 16,16-dimethyl prostaglandin E2

1 reference

7 January 2021

Hepatocyte membrane stabilization by prostaglandins E1 and E2: Favorable effects on rat liver injury

1 reference

7 January 2021

The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs

1 reference

7 January 2021

Regulation by PGE2 of the production of interleukin-6, macrophage colony stimulating factor, and vascular endothelial growth factor in human synovial fibroblasts

1 reference

7 January 2021

Prostaglandin E2 protects the heart from ischemia-reperfusion injury via its receptor subtype EP4.

1 reference

7 January 2021

Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels

1 reference

7 January 2021

Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart

1 reference

7 January 2021

Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia.

1 reference

7 January 2021

Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2.

1 reference

7 January 2021

Prostaglandin E(2) receptors, EP2 and EP4, differentially modulate TNF-alpha and IL-6 production induced by lipopolysaccharide in mouse peritoneal neutrophils

1 reference

7 January 2021

Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists

1 reference

7 January 2021

Distinct patterns of chemokine expression are associated with leukocyte recruitment in alcoholic hepatitis and alcoholic cirrhosis

1 reference

7 January 2021

Chemokines in liver inflammation and fibrosis

1 reference

7 January 2021

Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329.

1 reference

7 January 2021

A novel prostaglandin E receptor subtype agonist, 0N0-4819, attenuates acute experimental liver injury in rats

1 reference

7 January 2021

Prostaglandin E1 administration following orthotopic liver transplantation: a randomized prospective multicenter trial

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20827

1 reference

24 December 2017

1 reference

24 December 2017